ACSH Invited to White House to Advise on Tobacco Harm Reduction - American Council on Science and Health
"The regulatory assessment on small businesses, and the cost-benefit analysis, are separate issues that OMB is considering. We instead care about keeping a harm reduction and smoking cessation tool available to smokers who want to quit. So our specific recommendation was that the “substantial equivalence” date — the date at which products could be allowed to continue to exist without going through new regulatory review — be changed from early 2007 to the date that OIRA puts its stamp on the new regulations.
"The regulatory assessment on small businesses, and the cost-benefit analysis, are separate issues that OMB is considering. We instead care about keeping a harm reduction and smoking cessation tool available to smokers who want to quit. So our specific recommendation was that the “substantial equivalence” date — the date at which products could be allowed to continue to exist without going through new regulatory review — be changed from early 2007 to the date that OIRA puts its stamp on the new regulations.